Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis

Federico Rodríguez-pérez, Carlos M Isales, Roberto J. Groszmann

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Platelet cytosolic calcium concentration ([Ca2+]I) has been proposed to reflect changes in vascular smooth muscle cells. This study investigated if the platelet [Ca2+]I is altered in cirrhotic patients and determined its relationship with peripheral hemodynamics and peptide levels. Methods: Fourteen patients with cirrhosis and 11 healthy, age- and sex-matched controls had blood samples taken for determining platelet [Ca2+]I and glucagon, substance P (SP), and vasoactive intestinal peptide (VIP) values. Mean arterial pressure (MAP) and forearm blood flow (FBF) were measured on the same day of blood sampling. Forearm vascular resistance (FVR) was calculated. Results: Patients with cirrhosis had lower platelet [Ca2+]I (50.1 ± 2 vs. 73.0 ± 5 nmol/L; P < 0.001) than normal controls. Glucagon levels were significantly higher in patients with cirrhosis, but there was no difference in SP or VIP levels in both groups. MAP (80.5 ± 3 vs. 94.7 ± 3; P < 0.005) and FVR (20.1 ± 1 vs. 36.3 ± 2; P < 0.001) were significantly lower in patients with cirrhosis. A significant correlation was observed between platelet [Ca2+]I and MAP in patients with cirrhosis (r = 0.81; P < 0.001), between platelet [Ca2+]I and FVR (r = 0.87; P < 0.001), and between platelet [Ca2+]I and diastolic blood pressure (r = 0.78; P < 0.001). No correlation was found between platelet [Ca2+]I and peptide levels. Conclusions: Patients with cirrhosis have a significant reduction in the platelet [Ca2+]I. This finding correlates well with peripheral hemodynamics. Platelets may be a useful tool to study the etiologic mechanisms leading to the vasodilation of chronic liver disease.

Original languageEnglish (US)
Pages (from-to)863-867
Number of pages5
JournalGastroenterology
Volume105
Issue number3
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Liver Cirrhosis
Blood Platelets
Hemodynamics
Calcium
Peptides
Fibrosis
Forearm
Vascular Resistance
Arterial Pressure
Vasoactive Intestinal Peptide
Substance P
Glucagon
Blood Pressure
Vascular Smooth Muscle
Vasodilation
Smooth Muscle Myocytes
Liver Diseases
Chronic Disease

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis. / Rodríguez-pérez, Federico; Isales, Carlos M; Groszmann, Roberto J.

In: Gastroenterology, Vol. 105, No. 3, 01.01.1993, p. 863-867.

Research output: Contribution to journalArticle

Rodríguez-pérez, Federico ; Isales, Carlos M ; Groszmann, Roberto J. / Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis. In: Gastroenterology. 1993 ; Vol. 105, No. 3. pp. 863-867.
@article{024b612103ef42e086ad79342db38032,
title = "Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis",
abstract = "Background: Platelet cytosolic calcium concentration ([Ca2+]I) has been proposed to reflect changes in vascular smooth muscle cells. This study investigated if the platelet [Ca2+]I is altered in cirrhotic patients and determined its relationship with peripheral hemodynamics and peptide levels. Methods: Fourteen patients with cirrhosis and 11 healthy, age- and sex-matched controls had blood samples taken for determining platelet [Ca2+]I and glucagon, substance P (SP), and vasoactive intestinal peptide (VIP) values. Mean arterial pressure (MAP) and forearm blood flow (FBF) were measured on the same day of blood sampling. Forearm vascular resistance (FVR) was calculated. Results: Patients with cirrhosis had lower platelet [Ca2+]I (50.1 ± 2 vs. 73.0 ± 5 nmol/L; P < 0.001) than normal controls. Glucagon levels were significantly higher in patients with cirrhosis, but there was no difference in SP or VIP levels in both groups. MAP (80.5 ± 3 vs. 94.7 ± 3; P < 0.005) and FVR (20.1 ± 1 vs. 36.3 ± 2; P < 0.001) were significantly lower in patients with cirrhosis. A significant correlation was observed between platelet [Ca2+]I and MAP in patients with cirrhosis (r = 0.81; P < 0.001), between platelet [Ca2+]I and FVR (r = 0.87; P < 0.001), and between platelet [Ca2+]I and diastolic blood pressure (r = 0.78; P < 0.001). No correlation was found between platelet [Ca2+]I and peptide levels. Conclusions: Patients with cirrhosis have a significant reduction in the platelet [Ca2+]I. This finding correlates well with peripheral hemodynamics. Platelets may be a useful tool to study the etiologic mechanisms leading to the vasodilation of chronic liver disease.",
author = "Federico Rodr{\'i}guez-p{\'e}rez and Isales, {Carlos M} and Groszmann, {Roberto J.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1016/0016-5085(93)90906-S",
language = "English (US)",
volume = "105",
pages = "863--867",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis

AU - Rodríguez-pérez, Federico

AU - Isales, Carlos M

AU - Groszmann, Roberto J.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Background: Platelet cytosolic calcium concentration ([Ca2+]I) has been proposed to reflect changes in vascular smooth muscle cells. This study investigated if the platelet [Ca2+]I is altered in cirrhotic patients and determined its relationship with peripheral hemodynamics and peptide levels. Methods: Fourteen patients with cirrhosis and 11 healthy, age- and sex-matched controls had blood samples taken for determining platelet [Ca2+]I and glucagon, substance P (SP), and vasoactive intestinal peptide (VIP) values. Mean arterial pressure (MAP) and forearm blood flow (FBF) were measured on the same day of blood sampling. Forearm vascular resistance (FVR) was calculated. Results: Patients with cirrhosis had lower platelet [Ca2+]I (50.1 ± 2 vs. 73.0 ± 5 nmol/L; P < 0.001) than normal controls. Glucagon levels were significantly higher in patients with cirrhosis, but there was no difference in SP or VIP levels in both groups. MAP (80.5 ± 3 vs. 94.7 ± 3; P < 0.005) and FVR (20.1 ± 1 vs. 36.3 ± 2; P < 0.001) were significantly lower in patients with cirrhosis. A significant correlation was observed between platelet [Ca2+]I and MAP in patients with cirrhosis (r = 0.81; P < 0.001), between platelet [Ca2+]I and FVR (r = 0.87; P < 0.001), and between platelet [Ca2+]I and diastolic blood pressure (r = 0.78; P < 0.001). No correlation was found between platelet [Ca2+]I and peptide levels. Conclusions: Patients with cirrhosis have a significant reduction in the platelet [Ca2+]I. This finding correlates well with peripheral hemodynamics. Platelets may be a useful tool to study the etiologic mechanisms leading to the vasodilation of chronic liver disease.

AB - Background: Platelet cytosolic calcium concentration ([Ca2+]I) has been proposed to reflect changes in vascular smooth muscle cells. This study investigated if the platelet [Ca2+]I is altered in cirrhotic patients and determined its relationship with peripheral hemodynamics and peptide levels. Methods: Fourteen patients with cirrhosis and 11 healthy, age- and sex-matched controls had blood samples taken for determining platelet [Ca2+]I and glucagon, substance P (SP), and vasoactive intestinal peptide (VIP) values. Mean arterial pressure (MAP) and forearm blood flow (FBF) were measured on the same day of blood sampling. Forearm vascular resistance (FVR) was calculated. Results: Patients with cirrhosis had lower platelet [Ca2+]I (50.1 ± 2 vs. 73.0 ± 5 nmol/L; P < 0.001) than normal controls. Glucagon levels were significantly higher in patients with cirrhosis, but there was no difference in SP or VIP levels in both groups. MAP (80.5 ± 3 vs. 94.7 ± 3; P < 0.005) and FVR (20.1 ± 1 vs. 36.3 ± 2; P < 0.001) were significantly lower in patients with cirrhosis. A significant correlation was observed between platelet [Ca2+]I and MAP in patients with cirrhosis (r = 0.81; P < 0.001), between platelet [Ca2+]I and FVR (r = 0.87; P < 0.001), and between platelet [Ca2+]I and diastolic blood pressure (r = 0.78; P < 0.001). No correlation was found between platelet [Ca2+]I and peptide levels. Conclusions: Patients with cirrhosis have a significant reduction in the platelet [Ca2+]I. This finding correlates well with peripheral hemodynamics. Platelets may be a useful tool to study the etiologic mechanisms leading to the vasodilation of chronic liver disease.

UR - http://www.scopus.com/inward/record.url?scp=0027169493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027169493&partnerID=8YFLogxK

U2 - 10.1016/0016-5085(93)90906-S

DO - 10.1016/0016-5085(93)90906-S

M3 - Article

C2 - 7689521

AN - SCOPUS:0027169493

VL - 105

SP - 863

EP - 867

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 3

ER -